These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 38693059
1. Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease. Yee MEM, Covington ML, Zerra PE, McCoy JW, Easley KA, Joiner CH, Bryksin J, Francis RO, Lough CM, Patel N, Kutlar A, Josephson CD, Roback JD, Stowell SR, Fasano RM. Transfusion; 2024 Jun; 64(6):1109-1115. PubMed ID: 38693059 [Abstract] [Full Text] [Related]
3. Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approach. Gerritsma JJ, van der Bolt N, van Bruggen R, Ten Brinke A, van Dam J, Guerrero G, Vermeulen C, de Bruin S, Vlaar APJ, Biemond BJ, Nur E, van der Schoot E, Fijnvandraat K, SCORE consortium. Transfusion; 2022 Oct; 62(10):1984-1996. PubMed ID: 35916478 [Abstract] [Full Text] [Related]
4. Glucose-6-phosphate-dehydrogenase deficient red blood cell units are associated with decreased posttransfusion red blood cell survival in children with sickle cell disease. Sagiv E, Fasano RM, Luban NLC, Josephson CD, Stowell SR, Roback JD, Francis RO, Yee MEM. Am J Hematol; 2018 May; 93(5):630-634. PubMed ID: 29377292 [Abstract] [Full Text] [Related]
5. Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease. Yee ME, Francis RO, Luban NLC, Easley KA, Lough CM, Roback JD, Josephson CD, Fasano RM. Transfusion; 2022 Mar; 62(3):551-555. PubMed ID: 35044697 [Abstract] [Full Text] [Related]
6. Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units. Le Gallo M, Moutereau S, Gentil M, Pirenne F. Transfus Clin Biol; 2024 Aug; 31(3):130-134. PubMed ID: 38462030 [Abstract] [Full Text] [Related]
7. Acquired hemoglobin variants and exposure to glucose-6-phosphate dehydrogenase deficient red blood cell units during exchange transfusion for sickle cell disease in a patient requiring antigen-matched blood. Raciti PM, Francis RO, Spitalnik PF, Schwartz J, Jhang JS. J Clin Apher; 2013 Aug; 28(4):325-9. PubMed ID: 23450789 [Abstract] [Full Text] [Related]
8. Mathematical calculation of lifespan of transfused RBCs in sickle cell disease patients. Kim J, Usmani A, De Simone N, Sarode R. Transfus Apher Sci; 2018 Feb; 57(1):46-49. PubMed ID: 29196100 [Abstract] [Full Text] [Related]
9. Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism. Culp-Hill R, Srinivasan AJ, Gehrke S, Kamyszek R, Ansari A, Shah N, Welsby I, D'Alessandro A. Transfusion; 2018 Dec; 58(12):2797-2806. PubMed ID: 30265764 [Abstract] [Full Text] [Related]
11. Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy. Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Roback JD, Fasano RM. Transfusion; 2018 Jun; 58(6):1363-1371. PubMed ID: 29664198 [Abstract] [Full Text] [Related]
12. Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice. Osei-Hwedieh DO, Kanias T, Croix CS, Jessup M, Xiong Z, Sinchar D, Franks J, Xu Q, M Novelli E, Sertorio JT, Potoka K, Binder RJ, Basu S, Belanger AM, Kim-Shapiro DB, Triulzi D, Lee JS, Gladwin MT. EBioMedicine; 2016 Sep; 11():239-248. PubMed ID: 27523807 [Abstract] [Full Text] [Related]
13. Red blood cell mechanical sensitivity improves in patients with sickle cell disease undergoing chronic transfusion after prolonged, subhemolytic shear exposure. Simmonds MJ, Suriany S, Ponce D, Detterich JA. Transfusion; 2018 Dec; 58(12):2788-2796. PubMed ID: 30325033 [Abstract] [Full Text] [Related]
14. The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center. Hindawi S, Badawi M, Elfayoumi R, Elgemmezi T, Al Hassani A, Raml M, Alamoudi S, Gholam K. Transfusion; 2020 Feb; 60 Suppl 1():S15-S21. PubMed ID: 32134130 [Abstract] [Full Text] [Related]
15. How do I incorporate red cell genotyping to improve chronic transfusion therapy? Van Buren NL, Gorlin JB, Corby SM, Cassidy S, FritchLilla S, Nelson SC, Westhoff CM. Transfusion; 2020 Jan; 60(1):16-25. PubMed ID: 31758587 [Abstract] [Full Text] [Related]
17. In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation. Leonard AK, Furstenau D, Inam Z, Luckett C, Chu R, Demirci S, Essawi K, Gudmundsdottir B, Hinds M, DiNicola J, Li Q, Eaton WA, Cellmer T, Wang X, Thein SL, Macari ER, VanNest S, Hsieh MM, Bonner M, Pierciey FJ, Tisdale JF. Blood Adv; 2024 Apr 09; 8(7):1806-1816. PubMed ID: 38181784 [Abstract] [Full Text] [Related]
18. Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease. Lopez Domowicz DA, Welsby I, Esther CR, Zhu H, Marek RD, Lee G, Shah N, Poisson JL, McMahon TJ. Blood Transfus; 2020 May 09; 18(3):200-207. PubMed ID: 32203007 [Abstract] [Full Text] [Related]
19. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Bonin P, Rodet M, Chami B, Galacteros F, Bierling P, Noizat-Pirenne F. Transfusion; 2009 Sep 09; 49(9):1785-92. PubMed ID: 19413729 [Abstract] [Full Text] [Related]